Artemis Medicare commences Raipur hospital operations

2 min read     Updated on 09 Jul 2026, 01:20 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Artemis Medicare Services Limited commenced operations of its 300-bed Artemis Shanti Hospital in Raipur on July 9, 2026, expanding its footprint in Central India. The multi-specialty facility is designed to offer tertiary and quaternary care across key medical specialties. This expansion follows the company's strong FY26 financial performance, where standalone revenue rose to ₹1,06,049.17 lacs and consolidated revenue reached ₹1,08,124.24 lacs.

powered bylight_fuzz_icon
44973490

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services Limited has commenced operations of Artemis Shanti Hospital in Raipur, Chhattisgarh, effective July 9, 2026. This 300-bed multi-specialty facility marks a significant milestone in the company's expansion into Central India, bringing advanced tertiary and quaternary care to the region. The development follows the company's earlier agreement to manage the hospital, reinforcing its strategy to create a geographically diversified healthcare network.

Raipur Operations and Facility Details

The newly operational hospital is designed as a modern multi-specialty healthcare destination equipped with state-of-the-art operation theatres, advanced intensive care units, and modern diagnostic facilities. Key specialties include cardiology, oncology, neurosciences, orthopaedics, nephrology, critical care, and emergency medicine. Strategically located in Raipur, the facility aims to serve a catchment area extending across Chhattisgarh and neighbouring states, reducing the need for patients to travel to metro cities for complex treatments.

Parameter Details
Hospital Name Artemis Shanti Hospital, Raipur
Commencement Date July 9, 2026
Capacity 300 beds
Location Raipur, Chhattisgarh
Type Multi-specialty tertiary care

Strategic Expansion Context

The launch of the Raipur hospital is part of Artemis Medicare's broader expansion drive. The company is actively scaling its presence through multiple initiatives, including a new 110-bed facility in Mauritius under the name "Artemis Cascavelle Hospital," a Memorandum of Understanding for a ~650-bed facility under the "VIMHANS ARTEMIS HOSPITAL" brand in South Delhi, and a heart and lung transplant program in collaboration with KIMS Hospitals, Hyderabad. The company operates its flagship facility in Gurugram, which holds JCI and NABH accreditations.

FY 2025-26 Financial Performance

Artemis Medicare reported strong financial results for the financial year ended March 31, 2026. On a standalone basis, revenue from operations increased to ₹1,06,049.17 lacs from ₹91,326.13 lacs in the previous year, while EBITDA rose to ₹21,503.08 lacs from ₹18,275.52 lacs. Consolidated revenue from operations grew to ₹1,08,124.24 lacs from ₹93,691.67 lacs, with consolidated EBITDA reaching ₹21,800.58 lacs compared to ₹18,477.55 lacs in FY25. Finance costs declined to ₹2,694.40 lacs from ₹3,048.26 lacs on a standalone basis.

Particulars Standalone FY26 (₹ in Lacs) Standalone FY25 (₹ in Lacs) Consolidated FY26 (₹ in Lacs) Consolidated FY25 (₹ in Lacs)
Revenue from Operations 1,06,049.17 91,326.13 1,08,124.24 93,691.67
Total Income 1,09,039.65 94,617.63 1,11,107.16 96,990.26
EBITDA 21,503.08 18,275.52 21,800.58 18,477.55
Profit Before Tax 13,868.45 10,925.46 13,917.78 10,766.58
Profit After Tax 10,344.15 8,345.78 10,371.52 8,217.62
Total Comprehensive Income 10,327.77 8,337.38 10,353.47 8,207.78

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
+7.72%+7.78%+13.71%+26.28%+25.33%+696.48%

What is the projected timeline for the Raipur facility to reach full occupancy and achieve break-even?

How will the capital expenditure for the new Raipur and Mauritius facilities impact the company's leverage ratios in the coming fiscal year?

What are the revenue contribution targets expected from the Central India region over the next three years?

Artemis Medicare Services
View Company Insights
View All News
like19
dislike

Artemis Medicare Services Files BRSR for FY2025-26 with ESG Disclosures

6 min read     Updated on 08 Jul 2026, 06:42 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Artemis Medicare Services Limited submitted its FY2025-26 BRSR on July 7, 2026, covering workforce composition, ESG governance, environmental metrics including total energy consumption of 70,736 GJ and Scope 1 emissions of 2,680.99 metric tonnes CO2 equivalent, sustainability initiatives such as IGBC Platinum Rating and rooftop solar installations, stakeholder grievance data, and CSR programmes benefiting over 58,000 persons from vulnerable groups.

powered bylight_fuzz_icon
44980738

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 on July 7, 2026, in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was submitted by Poonam Makkar, Company Secretary and Compliance Officer, and forms part of the company's Annual Report for FY2025-26. The disclosures are made on a standalone basis, covering the entity's operations at three national facilities, with no international offices.

Corporate Overview and Business Activities

Artemis Medicare Services Limited, incorporated in 2004, operates from its corporate address at Artemis Hospital, Sector-51, Gurugram-122001, Haryana. The company's paid-up capital stands at Rs. 15,83,06,247. The following table summarises the company's primary business activity and its contribution to total turnover:

Parameter: Details
Main Activity: Healthcare Services
Business Activity: Multi-specialty Medical Services
% of Turnover: 99.56%
NIC Code: 86100
Reporting Boundary: Standalone Basis
Financial Year: 2025-26

The company has one holding company (Constructive Finance Private Limited) and one subsidiary (Artemis Cardicare Private Limited, with a 65% shareholding). Neither entity participates in the Business Responsibility initiatives of the listed entity.

Workforce Composition and Employee Benefits

The BRSR provides detailed disclosures on the company's workforce for FY2025-26. The total employee count stands at 399, comprising 291 males (72.93%) and 108 females (27.07%). The total worker count is 1,677, comprising 746 males (44.48%) and 931 females (55.52%). The Board of Directors comprises 10 members, of whom 3 (30.00%) are female. Key Managerial Personnel total 3, of whom 2 (66.67%) are female.

The following table presents employee and worker turnover rates across three financial years:

Category: FY2025-26 Male FY2025-26 Female FY2025-26 Total FY2024-25 Male FY2024-25 Female FY2024-25 Total FY2023-24 Male FY2023-24 Female FY2023-24 Total
Permanent Employees: 13.73% 9.09% 12.53% 11.52% 4.55% 9.80% 13.74% 20.12% 15.36%
Permanent Workers: 42.41% 50.58% 46.99% 40.03% 49.54% 45.26% 35.71% 50.72% 43.72%

All permanent employees and workers receive remuneration above the minimum wage. The median remuneration for key categories in FY2025-26 is detailed below:

Category: Male Number Male Median Remuneration Female Number Female Median Remuneration
Board of Directors: Nil Nil 1 Rs. 5,268.59 Lacs
Key Managerial Personnel: 1 Rs. 113.74 Lacs 1 Rs. 69.61 Lacs
Employees other than BoD and KMP: 290 Rs. 11.32 Lacs 106 Rs. 10.12 Lacs
Workers: 746 Rs. 4.41 Lacs 931 Rs. 3.84 Lacs

Gross wages paid to females as a percentage of total wages stood at 41.64% in FY2025-26, compared to 40.82% in FY2024-25. Well-being measures cost incurred as a percentage of total revenue was 0.43% in FY2025-26 and 0.47% in FY2024-25. The Lost Time Injury Frequency Rate (LTIFR) and total recordable work-related injuries for both employees and workers were nil in both FY2025-26 and FY2024-25. No fatalities or high-consequence work-related injuries were reported in either year.

ESG Governance and Policy Framework

The company's ESG governance is overseen by a Business Responsibility and Sustainability Committee. The highest authority responsible for implementation and oversight of Business Responsibility policies is Dr. Devlina Chakravarty, Managing Director. Key policies—including the Business Responsibility and Sustainability Policy, Code of Conduct for Directors and Senior Management, Anti-Bribery Fraud and Corruption Policy, Corporate Social Responsibility Policy, Equal Employment Opportunity Policy, Privacy Policy, Related Party Transactions Policy, and Whistle Blower Policy—have all been approved by the Board and translated into procedures. Performance against policies and compliance with statutory requirements are reviewed annually by the Committee of the Board across all nine NGRBC principles.

The company holds accreditations and certifications mapped to its NGRBC principles, including Joint Commission International (JCI), National Accreditation Board for Hospitals and Healthcare Providers (NABH-H, NABH-BB, NABH-EC, NABH-NE, NABH-ES), National Accreditation Board for Testing and Calibration of Laboratories (NABL), and ISO 27001 (Information Security Management System).

Sustainability Initiatives and Environmental Performance

The company achieved the IGBC Platinum Rating certification during FY2025-26, reflecting its commitment to green building practices and sustainable infrastructure. An Organic Waste Composter (OWC) machine was operationalised for on-site treatment of organic waste. Key sustainability initiatives undertaken include:

  • Renewable Energy Adoption: Installation of rooftop solar power systems with capacities of 150 kW and 60 kW; installation of solar water heaters.
  • Energy Efficiency & Optimization: Installation of Variable Frequency Drives (VFDs) and heat pumps in HVAC systems; replacement of conventional fans with energy-efficient fans in cooling towers.
  • Emission Reduction & Air Quality Management: Installation of Retrofit Emission Control Devices (RECDs) in diesel generators to reduce particulate matter (PM), SOx, and NOx emissions; installation of a new diesel generator (DG) set with improved emission and efficiency standards.
  • Water Conservation: Installation of water aerators across facilities; enhancement of rainwater harvesting (RWH) capacity.
  • Transition to Cleaner Fuels: Replacement of Liquefied Petroleum Gas (LPG) with Piped Natural Gas (PNG) in kitchen operations.

The following table summarises key energy and environmental metrics for FY2025-26 and FY2024-25:

Parameter: FY2025-26 FY2024-25
Total energy consumed from renewable sources (GJ): 696 406
Total electricity from non-renewable sources (GJ): 62,309 57,306
Total fuel from non-renewable sources (GJ): 7,731 10,937
Total energy from non-renewable sources (GJ): 70,040 68,243
Total energy consumed (GJ): 70,736 68,649
Energy intensity per lacs rupee of turnover: 0.667 0.752
Total Scope 1 emissions (metric tonnes CO2 equivalent): 2,680.99 3,977.93
Total Scope 2 emissions (metric tonnes CO2 equivalent): 12,288.81 11,572.80
Total Scope 1 & 2 emission intensity per lacs rupee of turnover: 0.141 0.170
Total water withdrawal (kilolitres): 1,18,835 1,46,008
Total water consumption (kilolitres): 92,145 1,17,461
Water intensity per lacs rupee of turnover: 0.87 1.286
Total waste generated (metric tonnes): 274.71 267.43
Waste intensity per lacs rupee of turnover: 0.0026 0.0029

For FY2026-27, the company has set a target of approximately 30% reduction in Scope 2 emissions through a third-party offsite solar energy plant, to be introduced in a phased manner.

Stakeholder Grievances and Compliance

The company has grievance redressal mechanisms in place for all stakeholder groups. During FY2025-26, 148 customer complaints were filed (nil pending at year-end), compared to 553 in FY2024-25 (nil pending). One shareholder complaint was filed in FY2025-26 (nil pending), with nil in FY2024-25. Community complaints stood at nil in FY2025-26 versus 2 in FY2024-25. No complaints related to sexual harassment, discrimination, child labour, forced labour, or wages were filed in either FY2025-26 or FY2024-25.

A monetary penalty of Rs. 10,00,000 was imposed by the Office of the Collector of Stamps, Government of NCT of Delhi, under NGRBC Principle 1, related to delayed filing of an application for determination of stamp duty. No appeal has been preferred. The company reported compliance with all applicable environmental laws, regulations, and guidelines in India, and received no adverse orders from regulatory authorities related to anti-competitive conduct during the current financial year.

CSR and Community Engagement

The company is a member of several industry associations including ASSOCHAM (National), PHD Chamber of Commerce and Industry (National), Federation of Indian Industry Haryana (State), and others. CSR projects undertaken during FY2025-26 include the Green Belt Initiative, Boondh-Rainwater Conservation (benefiting 7,107 persons, 100% from vulnerable groups), Conservation of Solar Energy (benefiting 2,300 persons, 100% from vulnerable groups), It's a FIGHt bK-Tuberculosis Elimination Programme (benefiting 45,553 persons, 100% from vulnerable groups), and Menstrual Health & Hygiene Management (benefiting 4,000 persons, 100% from vulnerable groups). Procurement directly sourced from MSMEs/small producers stood at 52.02% in FY2025-26 versus 53.17% in FY2024-25, and 97.94% was sourced directly from within India in FY2025-26.

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
+7.72%+7.78%+13.71%+26.28%+25.33%+696.48%

How will the planned 30% reduction in Scope 2 emissions via the third-party offsite solar plant impact Artemis Medicare's operational costs and energy reliability in FY2026-27?

Will the significant decrease in customer complaints from 553 to 148 in FY2025-26 be sustained through the implementation of new patient care protocols or digital feedback systems?

Does the high turnover rate among permanent workers (46.99%) pose a risk to service quality, and what retention strategies are being prioritized to stabilize this workforce?

Artemis Medicare Services
View Company Insights
View All News
like17
dislike

More News on Artemis Medicare Services

1 Year Returns:+25.33%